Bacterin International Holdings (AMEX:BONE), a developer of bone graft material and antimicrobial coatings for medical applications, said it has been invited to present at the Stifel Nicolaus Healthcare Conference.
The conference is set to take place at the Four Seasons Hotel in Boston, Massachusetts from September 7 to 9, 2011.
Bacterin’s Chief Executive, Guy Cook, as well as John Gandolfo, Chief Financial Officer, are scheduled to present on Thursday, September 8, at 9:10 a.m. Eastern time, with one-on-one meetings held during the day.
The company said in a statement that management plans to discuss the company's business plan and objectives for the rest of the year. The presentation will be available via webcast atwww.veracast.com/webcasts/stifel/healthcare2011/61203587.cfm
A replay link will also be available for 90 days after the live presentation on the company's website.
Last month, the company reported record sales during the second-quarter of $7.5 million, up 25% sequentially and 135% year-over-year.
Earnings before interest, taxes, depreciation and amortization swung to a positive $35,000 for the first time ever, as compared to a loss of nearly $1 million one year ago.
Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone repair and dermal growth. The company's medical division also develops antimicrobial coatings that inhibit contamination.
The Belgrade, Montana-based company’s shares grew 7 cents, or 3.54%, to $2.05 late Wednesday afternoon on the AMEX Exchange.
No comments:
Post a Comment